5-point plan announced UK Prime Minister to reduce #immigration x.com/10DowningStree… If implemented sooner would've impacted 9 in my team😟 Our #academic team #FoulkesAward2021 #RSCrickAward2021 #JosefSteiner2019 In 10 yrs, we hailed frm 18 countries to serve #NHS & UK science

Today in the The Lancet, we UK geneticists argue: "Population screening requires robust evidence—genomics is no exception" Anneke Lucassen, Helen Firth, Bill Newman, Caroline Wright, Margaret McCartney, @wilkie_lab, Robin Lachmann,TomlinsonGroup,Lucy Raymond authors.elsevier.com/a/1iD4W_3CjG8W…

If you're involved or interested in clinical genetics - immediately stop what you're doing and read this. A brilliantly thoughtful piece in The Lancet considering costs/benefits/implications of population screening and genomics.

As a non-genomics expert, I was really moved by this! Parallels to digital health where we are often swept away by tech hype, rather than evidence. Just because we can, doesn't mean we should... saira ghafur @BeyerKathrin Niels Peek Matthew Lee Pritesh Mistry Christabel Pankhurst Institute UoM

Dian Donnai Anneke Lucassen Bill Newman Helen Firth Much appreciated feedback, Dian Donnai. Thank you. For any whipper-snappers, Dian Donnai is genetics royalty. She was discovering new syndromes and mapping genes when you were still in short trousers. These words could not have come from a wiser voice....

Academic clinician–scientists risk becoming an endangered species. World View from stephen o'rahilly (its pronounced O-RA-hill-EEE) Cambridge University nature.com/articles/s4159…

Many congratulations

Opportunities for #pharmacogenetic panel testing to guide treatment selection across a person's lifetime. Great example from the PROGRESS PGx study JessicaKPharmacist NHS Genomic Medicine Service

Huge congratulation to Elijah Behr, Professor of Cardiovascular Medicine at St George’s, University of London and Honorary Consultant Cardiologist at St George's NHS FT who has been awarded Hero of the Year at British Heart Foundation’s Heart Hero Awards 2023. Learn more: sgul.ac.uk/news/professor…

Fantastic NIHR Manchester Biomedical Research Centre #rareconditions theme Xmas seminar with groundbreaking work from Rob Wynn Adam Jackson Tom Wright Evolution, Infection and Genomics (EIG) UoM Manchester Rare Conditions Centre

Looking for a new exciting role for 2024 . We are seeking a skilled and enthusiastic Support Specialist to help promote DECIPHER. Apply for this part time role at: embl.org/jobs/position/… pic.x.com/i9crjj77es

"The main reason I wanted to get involved with research was a strong desire to improve services not just locally but influence service care more broadly, my desire to influence that change remains just as strong today...." Dr. Paul French. #SPDMC (Research Council)

Wishing you all a very Happy Holidays from the Genes & Health Team 🧬🌟

Calling all #cardiology professionals in the North West! Join us for a cardiology #genomic study day on 28/2/2024. More info available here: bit.ly/CGSD24 Bill Newman Rhys Beynon

Unique

Deep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype - by ⁦Rob Harkness⁩ ⁦Ray O'Keefe⁩ ⁦Evolution, Infection and Genomics (EIG) UoM⁩ ⁦Manchester Rare Conditions Centre⁩ ⁦Genomics England⁩ sciencedirect.com/science/articl…

I’ve updated the blog on our website to more accurately report the timelines associated with the work in the paper   bit.ly/GDF15_NVP_HG_B…

We describe de novo intellectual disability monogenic syndromes from the Indian population in the journal European Journal of Human Genetics published by Springer Nature. Congratulations to the lead fellows who put this together Shruti_Pande and Purvi Majethia Medical Genetics Manipal

Look at the new resource on genetics of Movement disorders, neurodegenerative diseases and neurocutaneous syndromes at web.xpeer.app/web/en/courses…$ Free to register European Society of Human Genetics (ESHG) eshg_young EPNS

Just before the end of the year, we initiate the Twitter account for our brand-new lab at the IIBM. Starting the Pharmacogenomics and Tumor Biomarkers Group Pharmacogenomics & Tumor Biomarkers Group is a very exciting moment, and a challenge at the same time.